Last reviewed · How we verify
NCT06982417
InsightRP2 Registry
trial in RP2-associated Retinitis Pigmentosa in 200 participants. Currently enrolling.
1 May 2045
Quick facts
| Lead sponsor | University of Göttingen |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 May 2025 |
| Primary completion | 1 May 2045 |
| Estimated completion | 1 May 2045 |
| Sites | 1 location across Germany |
Conditions studied
- RP2-associated Retinitis Pigmentosa — all drugs for RP2-associated Retinitis Pigmentosa →
- X-Linked Retinitis Pigmentosa (XLRP) — all drugs for X-Linked Retinitis Pigmentosa (XLRP) →
- Retinitis Pigmentosa 2 — all drugs for Retinitis Pigmentosa 2 →
Sponsor
University of Göttingen
Who can join
Eligibility, any sex, with RP2-associated Retinitis Pigmentosa or X-Linked Retinitis Pigmentosa (XLRP). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
InsightRP2 is a secure online patient registry specific to RP2-associated retinitis pigmentosa (RP). It is our goal to further the scientific understanding of this rare disease and to support research in to a gene therapy for RP2-associated RP. We collect medical, genetic and imaging data from people affected by RP2-associated RP and will coduct a natural history study as well as image analysis studies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06982417
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Göttingen trials
Trials by the same sponsor.
- NCT06441058 — Retrospective Database Study: Influence of Post-endodontic Restoration Placement on Survival of Root Canal-treated Teeth · completed
- NCT06129799 — Exercise CMR in (p)LF-LG AS · recruiting
- NCT05335616 — Behavioral Change Simulation Experiment Regarding Dentists' Repair Behavior · NA · completed
- NCT04914208 — Effect of Wearing Face Masks on Salivary Parameters and Halitosis · NA · completed
- NCT04648059 — Epigenetics in Lupus Nephritis · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06982417 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Göttingen
- Last refreshed: 21 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06982417.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing